期刊文献+

老年血液透析患者的临床特征分析 被引量:4

Clinical characteristics of the elderly patients with treatment of maintenance hemodialysis
暂未订购
导出
摘要 目的探讨老年维持性血液透析患者的临床特征。方法选择1993年3月~2010年5月间在杭州市中医院肾内科进行维持性血液透析治疗的167例老年血液透析患者(≥60岁)和同期140例非老年维持性血液透析患者,对比分析两组的病因、营养指标、透析效果、临床转归等。结果继发性肾脏疾病在老年组发病率增加。两组患者间总胆固醇(TC)、甘油三酯(TG)、钙(Ca)、甲状旁腺激素(PTH)、铁蛋白(Fer)及每月促红素用量无统计学差异(P〉0.05)。老年组透析前血浆白蛋白(Alb)、尿素氮(BUN)、血清肌酐(Cr)、磷(P)、舒张压、透析间期增重均低于非老年组,hsCRP水平高于非老年组P〈0.01)。两组间尿素氮清除效率(Kt/v)比无统计学差异。随访1年,老年组死亡16例,其中脑血管意外8例(50%),感染5例(31.2%),肿瘤1例(6.3%),心肌梗死1例(6.3%),高钾血症1例(6.3%);非老年组死亡6例,其中脑出血2例(33%),感染1例(16.6%),肾癌1例(16.6%),心肌梗死1例(16.6%),高钾血症1例(16.6%)。非老年组另有5例改行肾移植,1例改行腹透。结论随着透析技术不断进步,老年透析患者透析质量改善,生存期延长,脑血管并发症和感染是主要死亡原因。 Objective To evaluate the clinical characteristics of elderly patients with end stage renal disease on maintenancehemodialysis. Methods Blood biochemistry tests, mortality rates and causes of death in the167 elderly hemodialysis patients and 140 non-elderly hemodialysis patients were analyzed. Results Secondary kidney disease in elderly patients was higher than non-elderly hemodialysis patients. There were no significant differences in the serum calcium, parathyroid hormone, ferritin level, erythropoietin dosage and KT/V between the two groups. Compared with the non-elderly hemodialysis patients, serum albumin, blood urea nitrogen, serum creatinine, phosphate, diastotic blood pressure and weight gain were lower in elderly patients (P〈0.01). Serum hsCRP level was higher in elderly patients (P〈0.01). After 1 year, 16 elderly patients and 6 non-edlerly patients died. In elderly patients, the incidence of cerebral vascular accident, infection, tumor, myocardial infarction and hyperkalemia were 50 %, 31.2 %, 6.3 %, 6.3 % and 6.3 %, respectively. In nonelderly patients, the incidence of cerebral bleeding, infection, tumor, myocardial infarction and hyperkalemia were 33 %, 16.6 %, 16.6 %, 16.6 % and 16.6 %, respectively. Kidney transplantation was carried on 5 non-elderly patients and one patient was undergone peritoneal dialysis. Conclusions Along with the continuous advancing of hemodialysis technology, elderly dialysis patients have improved quality of dialysis and prolonged survival time. The primary causes of their death are cerebral vascular accident and infection.
出处 《老年医学与保健》 CAS 2011年第5期286-287,292,共3页 Geriatrics & Health Care
关键词 老年人 尿毒症 血液透析 Elderly Uremia Hemodialysis
  • 相关文献

参考文献5

二级参考文献22

  • 1张利,陈香美,申力军,张冬.老年血液透析患者死亡相关因素分析[J].中国老年学杂志,2005,25(4):359-361. 被引量:20
  • 2李惠群,陈世件,叶任高,许乃贵,刘思棋,罗秀兰.腹膜透析治疗慢性肾衰存活期、生存率及死因分析[J].中华肾脏病杂志,1994,10(2):87-90. 被引量:7
  • 3常明,刘红,刘书馨,腾兰波,王志宏,刘焱,赵华,付瑶,王伟.尿毒症患者血管钙化及相关因素的研究[J].中华肾脏病杂志,2006,22(9):578-579. 被引量:19
  • 4Qureshi AR, Alvestrand A, Divino - Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol, 2002,13 (Suppl 1 ) : S26 -S28.
  • 5Diepeveen SH, Wetzels JF, Bilo HJ, et al. Cholesterol in end - stage renal disease:the good, the bad or the ugly? Neth J Med, 2008,66(2) :53 - 61.
  • 6Baigent C, Landray MJ, Wheeler BC. Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials. Semin Dial, 2007,20(6) : 498 - 503.
  • 7Cordtz J,Ladefoged SD. Cardiovascular risk factors in hemodialysis patients - reverse epidemiology. Ugeskr Laeger, 2007, 169 (33) :2609 - 2613.
  • 8Xue TL, Ma TL, Louis TA, et al. Forecast of the number of patient with end stage renal disease in the United States to the year 2010. J Am Soc Nephrol,2001,12(12).2753- 2758.
  • 9Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32(5 Suppl 3):S112 - S119.
  • 10叶任高,现代肾脏病学,1986年,162页

共引文献68

同被引文献30

  • 1王叶,陈健,陈治卿,陈鹭玲,黄春玲,刘莉莉,张忠英.老年妇女血清β-1型胶原C-末端肽与骨密度及骨质疏松症相关性分析[J].中国临床康复,2004,8(29):6304-6304. 被引量:14
  • 2邱明才,朱梅.如何正确理解骨质量[J].中华医学杂志,2005,85(11):723-724. 被引量:4
  • 3马特安,叶朝阳.血液透析及腹膜透析对老年患者生存期的影响及相关因素分析[J].中国中西医结合肾病杂志,2006,7(1):40-41. 被引量:18
  • 4Filip RS, Zagorski J. Age-and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Re- gion, Poland [J]. Ann Agric Environ Med, 2004,11 ( 2 ) : 255-9.
  • 5Jensen PB, Rasmussen HB, Pedersen FB, Serum concentration of the aminopropeptide of type I proeollagen in patients on haemo-and perito- neal dialysis [J ]. APMIS, 1997,105 ( 5 ) :371-7.
  • 6Ueda M, Inaba M, Okuno S, et al. Clinical usefulness of the serum N-ter- minal propeptide of type I collagen as a marker of bone formation in hemo- dialysis pafients[J]. Am J Kidney Dis,2002,40(4) :802-9.
  • 7Imanishi Y. Clinical aspect of recent pregrese in phosphate me- tabolism. Phosphate retension,a powerrul risk factor for morality in chronic kidney disease (CKD). Clin Calcium,2009,19:828 - 835.
  • 8叶任高.内科学[M].第4版,北京:人民卫生出版社,1998:511.
  • 9Kong X, Zhang L, Zhang L, et al. Mineral and bone disorder in chinese dialysis patients: a multicenter study. BMC Nephrol, 2012,13( 1 ) : 116.
  • 10Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol,2004,15 (8) :2208 -2218.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部